The Subject Expert Committee (SEC) had recommended granting permission to manufacture and market the drug for restricted use under emergency situations in the country for treatment of adult patients with COVID-19.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3qNwYGv
0 Comments